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We examined CD44 expression on Inelanocytes to 
begin to understand what role CD44 might have in 
the normal behavior of melanocytes and to provide a 
basis for comparing CD44 expression in melanoma 
cells. CD44 was expressed on the entire surface of 
melanocytes and accentuated at the tips of dendritic 
processes. Two predominant forms of CD44 are ex-
pressed on cultured human foreskin melanocytes. 
One form has the covalent addition of chondroitin 
sulfate, whereas the other form has no chondroitin 
sulfate. Both use the hematopoietic, or CD44H, core 
protein. Using polymerase chain reaction primers 
that span the site where alternative splicing of CD44 
E pid.e rmal m elanocytes norm. aLly reside in tI-.le ba.sa llayer of the epidermis and extend dendritic processes through the intercellul ar space between keratinocytes. Considerable attention has been directed toward un-derstanding th e molecular in teractions involved in m ela-
nocyte attachm ent to substrata (Zambruno ct ai , 1993; Hara ct ai , 
1994), but li ttle is known about the nature of receptor-ligand 
inte rac tions between melanocytes and keratin ocytes or between 
m elanocytes and mol ecular components o f the in tercellu lar space. 
Hya lu ronan is the only classical extracellular matrix molecule that 
has been identified in the in terce llu lar space (Tamm i et ai, 1988). 
The CD44 g lycoprote in s are type r transmembrane protein s, 
w hich are the product of a single gene. A hya luronan binding 
domain at its amino te rminus provides CD44 with a role in cel l-cell 
adhesion Ualkanen ct ai, 1987; Shimizu et ai, 1989; St John ct ai, 
1990; Birch el ai, 1991 ; Stamenkovic ct ai, 1991 ; H e et ai, 1992; 
Milstone ct ai, 1994) and cell adhesion to hyaluronan-coated 
substrata (Carter and Wayn er, 1988; Aruffo ct ai, 1990; Birch ct al 
1991 ; He ct ai, 1992 ; Jalkan en and Jalkanen 1992; Thomas ct ai, 
1992). Mol ecular he teroge neity of CD44, arising fi'om various 
form s of g lycosylation on the CD44 core protein and alternative 
splicing of the CD44 gene transcript, can signifi cantly alter ce ll 
beha vio r and motility. For examp le, some molecu les of CD44 arc 
expressed as chondroitin sulfate proteoglycans Oalkanen ct ai, 1988; 
Stamenkovic ct ai, 1991; Faassen et ai, 1992; Haggerty ct !II, 1992). 
The chondroitin sulfate chail1S enable those molec ules to adhere to 
coll agen (Carte r and Wayner, 1988; Faassen ct ai, 1992) and to 
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occurs, we found only the cDNA coding CD44H. 
12-0-Tetradecanoylphorbol 13-acetate increases the 
size of the chondroitin sulfate chain(s) attached to 
CD44 but not the proportion of CD44 molecules that 
carry chondroitin sulfate. Ninety percent of proteo-
glycans on melanocytes are chondroitin sulfate 
proteoglycans, and the CD44 chondroitin sulfate pro-
teoglycan represented 10% of that total. These data 
show that CD44H is expressed as a "part-time" 
chondroitin sulfate proteoglycan on normal cultured 
melanocytes. Key words: p,'oteoglyca.llladilesiolllkemtillo-
cyteltetmdeca.lloyl pllOrbol acetate (TPA). ] [""est DeI'IIIatoi 
106:1230-1235, 1996 
fibrone ctin Oalkanen and Jalkanen, 1992). One chondroitin sulfate 
proteoglycan form of CD44 see ms to account fo r an increase in cell 
motili ty and ability to invade co ll agen gels (Faassen et ai, 1992). 
Spl ice variants of CD44 are expressed by a variety of normal tissues 
and migratory cells (Brown et ai, 1991; Dougherty et ai, 1991; Arch 
et al 1992' Kugelman et al 1992)' certain sp lice variants may be asso~iated 'with increased ' metas;atic pot~ntial of tumor cell s 
(Gtinthert et " I, 1991 ; Matsumura and Tarin , 1992). 
The expression CD44 on the surface of m elanoma cells has been 
studi ed in attempts to relate quantitative and qua li tative differences 
in CD44 express ion to cell motility and metastatic potential (Birch 
et (/1, J 991; Hart ct ai, 1991; Faassen ct ai , 1992; Thomas et ai, 1992; 
East et ai , 1993; F'lassen ct a11993; T homas ct ai, 1993; Bartolazzi ef 
ai, 1994; Guo ct ai, '1994; van Muijen ct ai, 1995; Zhang cf ai, 1995). 
By contrast, CD44 expression on normal m elanocytes has been 
m entioned on ly in passing (van Muijen ei ai, 1995). Since alterna-
tive splicing of the CD44 gene transcript, variab le g lycosylation of 
the CD44 core protein, and quantitative differences in CD44 
ex pression on the cell surface have all been associated with 
alte rations in ce ll mobility, adhesiveness, and metastatic potential , 
we examined CD44 expression on cultured human foreskin epi-
derma l melanocytes. Our goals are to understand what role CD44 
might have in no rmal behavior of m elanocytes and to provide a 
basis of comparison for eva luating CD44 expression in m elanoma 
ce ll s. 
MATERIALS AND METH ODS 
Cell Culture All melanocyte cultures and culturc mediullls were pro-
vided by thc cel l culture fac ili ty ofthc Ya le Skill Discases R.esearch Center 
(Ncw Ha ven, CT) . Melanocytes werc cstablished frolll nconatal human 
foreskins in a growth mcdium containing H5 nM 12-0-tctradecanoylphor-
bol 13-acc tatc (Tl'A) (Funasak;, ('I (II, 1992; I-Iala\)"n ("{ nl. 1992) . TPA-free 
melanocytes wcre growlI in chemica lly dcfin cd PC- I mcdium (Hycor 
Uiol1lcdical. Ille., Portland, ME) supplcmcntcd with basic fibroblast growth 
u,ctor (1 U ng/ml). hepatocyte growth factor/scatter u,etor (40 ng/ ml), 
mast/stern ce ll growth factor (200 IIg/ml) , endothelilf-I (3 X 10- 8M) . and 
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heparin (1 ng/ llIl ) (Uolun el ai , 1995). R adi olabc led ce ll s we re prepared by 
the addition of r"Sl Na2 SO" (ca rrier-free. IC N R.ad iochemica ls. Costa 
Mesa, CAl (25 J.LC i/ llll ) to the growth medium for 72 h befo re harves ting. 
Keratin ocytcs were csta bUshcd fro n1 Ilconata lllllr11 311 foreskin s :"IS prev io usly 
descrjbed (Hagge rty ('I ai, 1992) . 
Irnmunoc ytoc hcluis try Me lal1 0cytcs were g rown 0 11 g lass coverslip s. 
fixed with acetone and methano l. reacted first with a 1 :200 dilution of 
Hermes- 3 and then with a flu o rescein isothiocyanate- conjugated goat 
anti-mouse monoclonal an tibody, and photographed using Kodak T MAX-
400 (Kodak. Rochester, NY). Herl11cs-3 (H-3) is a mouse monoclonal 
anti bo d y tbat binds an cpitope on the ex traceUul ar domain of CD 44, amino 
, terminal to the sp li ce site (Sa lllli el al. '1993). It was kjndl y provided by Dr. I Eugene J3 utcher (Stanfo rd Uni versity School of Medicine, Palo A lto, CAl. 
Extraction and Inll11Ul10prccipitatioll e ll s \vcrc extracted usin g 
ei ther a p revio usly desc ribed urea/Trito n X I 00 buffer (Haggerty cl ai, 1994) 
for djrect preparatio n of the proteoglyca n fraction by diethylaminoeth yl 
I (DEAE) - sepharose chro matography. or by using an acetate/Trito n X l 00 I buffer (Miettinen and J alkan en , 1994) for imlllunoprecipi ra tion (4 III I per 
conflu ent T75 Aask) . Immunoprccip itati o ll was perfo rmed by the method of 
Camp el al (1991). Briefl y, 0.5 1111 of ce ll extract was precleared with 
lepharose-bound goat anti- mouse Ig, followed by protein A sepharose I beads (~ha l'lnacia 13iotech. Uppsala, Sweden) . A 50% slurry (70 J.LI) of the 
H-3 anobody, hnked to protelll A sepharose beads (1 to 3 mg anobody/ml 
I ~f bead s) (H arlo and. Lane. 1988), w as used to illllllul.lOprccipitate CD 44 Isofonn s. After ",asillng as prevIously deSCribed, the IIn mLlne cOlllplexes 
were p rocessed fo r W e,te l'll blotting o r diges tion of glycosaminoglyca n 
chains. S ubsequent il111tlUn Oprec ipitatio ll of the extract \",jth a tTcsh aliquo t 
. ofH-3 -linkcd beads indicated tha t a single aliq uot of H-3-linked beads was 
sufficient to imlllunoprecipi tate all of the CD44 in a 0 .5-ml sample . 
I lmlD unOblOuing Dor blots we re perfo rmed as described by J alka nen el 
,/ (1985) with minor modifi catio ns previously described (H agge rty cF al. 
1992) . A ll samples fo r Weste rn blotting were electrophoretica lly separaced 
on a 3-1 3% line,,,' gradient sodium dodecyl sul f.,te (SDS)-polyacrylamjde 
gel e lectropho res is (PAGE) gel. Prestaincd molecular weight markers 
I (Biorad Laborato ri es , J<.i chmond. C Al were run fo r molecular Ill ass es tima-I non. ForW estern blots, the gel was placed in a T ransphor electrophoresis 
unjt (H oefer Scientifi c Instruments. San Frall cisco, CAl and transfe rred w 
Zetaprob e pape r (Biorad). using o ne-quarter strength Towbin buffer (Tow-
bin et ai , 1979; J alkanell c ( ai, 1985) at '100 l11amp fo r 12-1 8 h . Indirect 
imm uJl ostCl illin g w as lI sed to v islIaUze antigell s recognized by th e V~lri O lI S 
antibodies. In sOlne cases . a piece of ni trocellulose was placed between the 
gel and the Zetaprobe paper. This se rved to trap substances, perhaps 
I fragmen ted inll1111l1 obcads. that in tcrfc~,ed w itl.1 a l1 ~i gcn vis.ualiza ti.o n . Flu-orography was perfo rmed on ge ls by ImmersIon In Ampli fy (Amersham , 
. Napier, IL) fo r 30 mi n fo llowed by d rying and exposure w Kodak 
X-OMA T fi lm at 4°C. 
Enzym a ti c Digestion Lyophilized sa lllpies of melollocyte proteoglyca n 
were di gested wi th cho ndroitin ABC lyase (Oike el al. 1980), heparinase 
(Kato et ai , 1985) , or heparitinase (Kato cl ai, 1985) as prev iously described 
o-Iagger ty e/ al. '1992). Alk"Un e eliminatio n o f g lycosamiuoglycan chains 
was accompli shed w ith 0.05 M NaJ3H.1 in O.S M NaO H at 4°C for 24 h 
(Piepkonl r l al. 1990). T he rela tive amo unts ofglycosa minoglyc:1Il chains in 
digests were calcul ated by sumllling the coun ts in digested peaks a.nd 
divid i.ng by tota l coun ts in the applied aliquot . R ecovery of the label alter 
digestion was always grcate r than 95')1" of the origjnal aliquot. fmmun opre-
cipitates fro m melanocy te extract were digestcd by placing washed beads 
directly in to the same buffers used fo r diges ti on o f lyophili zed s,mlpl es . 
RNA I s olation Total RN A was iso la ted from onc conAuent T75 flas k of 
human e pidermal melanocytes 01' keratinocytes. Ce ll s we re lysed with 4 M 
guanidin i um thiocyanate, layered on a 5. 7M CsCI cushion and centrifuged 
ar 120,OOOg fo r tG h at 20°C . T he I~A pcllct was re suspended in T ri s-j ethylen e diamine tetraaceti c "cid buffe r, precip.itated three times wi th etha-
nol , and then resuspended in diethyl pyroca rbonate-treated water. T he I concentra tion of RN A w as estimated fi'om absorbance readings at 2GO nm. 
Rever se Transcription A 20-J.LJ reaction mi xture con tained 4 J.Lg of 
«)[al RNA. 50 111M Tris-H C I, pH 8.3, 54 mM KCI, 10 rnM MgCI2 • 10 111M 
J
' ditruothrc ito l, I rn M dNT Ps. 20 units of RN Aase inh ibi to r. 20 uni ts of av ian 
myelobl astosis virus reve rse tra nscriptase (Promcga \3 iotec, Mad ison. \,V I) 
. and 40 p m olcs of random hexa l1l ers. T he reaction proceeded fo r 15 rnin at 
room tem peraturc, IS min at 37°C , 45 min at 42°C . and was stopped by 
beating fo r 5 min at 95 °C. 
eDNA Amplific ation T he po lymerase chain reaction (P It) was per-
formed in a 5U J.L I re"ction mixture containing 4 J.LI of cD NA. J 00 pllloies 
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Figure L CD44 expression 011 melanocytes. An immunoAuo rescence 
photomicrograph shows hu man epidermal melanocytes stained w ith the 
anti-CD44 an tibody. H-3. No te the contin uo us stai ning at the cell surf.1ce 
and accentuatio n at the tips of dendri tic processes. 
of each primer. 1. 5 mM MgClo, 0.2 mM of deoxynucleotide triphosphates, 
and 1 .25 units of Taq DNA Po lymerase (Pro mega Bio tec). Each tube was 
denatured at 95°C for 5 min and then went thro ugh 35 cycles at 95 °C fo r 
1 min , 45- 56°C (dependent on the primer pair) for 1 min , and 72°C fo r 2.5 
min . T he products were separated o n a 2% agamse ge l impregna ted w ith 
cthid iull'l bro lliidc. and were pho tographed usin g an ul trav io let tranS IU t11i-
natol'. T he fo llowing CD44 primers arc identifi ed by the nucleotide 
numbering used in sequencing C D 44Epican (Kuge lman et al. 1992) : 
Fl03. S'-AGTACGTCTTCAAATACCATCTC_3' (nucleotides 669 - 692) 
FI 05. 5' -ACTGTACACCCCATCCCAG-3 ' (nucleotides 600 - 619) 
F107, 5'-ATTTCAACCACACCACGGGCT-3' (nucleotides 795- 816) 
Rl 04. 5 ' -GGTGCTGGAGA TAAAATCTTCA TC-3' (nucleotides 792- 768) 
RJ 06, 5' -TCCT GATAAGGAACGATTGAC-3' (nucleotides 1683-1 662) 
9. 5 ' -TCACCGACAGCACAGACAGAA-3' (nucleotides 634 - 65 5) 
AMP2. 5'-CCAAGATGATCAGCCAT TCTG-3' (nucleotides 1837- 18 16) 
Primers 9 and AMP2 span the alternati ve splice sitc and amplify an )' 
combination ofexons inserted between exollS 5 and 15. T he F1 03 and R I 04 
pair ampli fIes c"on 7; the Fl 05 and Fl 04 pair amplifies rhe 3' end of exon 
5 plus e"on 7; the F I03 and Rt 06 pa ir amplifies e"on 7 th ro ugh exon '14: 
the F I07 and R.I06 pair ampli fies cxon 8 through e"on 14 . 
R ESULTS 
Cell Surface Expression ofCD44 on Melanocytes C ultured, 
hum an n eon a ta l epidermal m e lan ocytes-he re afte r referred to as 
m e lan ocytes- ex pressed C D 44 over th e ir e n tire ceU surface (Fig 
1) . T he in ten sity of expressio n was accentua te d at the t ips of 
d e ndri t ic processes and in regio n s of m embran e ruffiin g n ear cell 
b o dies. CD44 w as a lso e xpressed o n microvillus proj ectio n s fro m 
the cell surface. 
Protein Variants and Glycoprotein Isoforms of CD44 on 
Melanocytes D etergent ex tracts of m e lan ocytes were resolved 
by SD S-PAGE, and CD44 species were identifi ed b y \ Ves te l11 blo ts 
using the H-3 an tibo d y. Figure 2 , Itji IflIIC, sh o w s th a t m elanocytes 
conta in ed an 85- 95- kOa fo rm ofCD44 and a h e te rogen eous sm ear 
of hig h e r m o lecul a r w e ight sp ecies. T h e sm alle r b and h as th e 
Illo bility of CD44H, th e stand ard o r cOlllmo n fo rm of CD44, and 
the sm ea r is characte ristic of p roteoglycan fo rm s of CD44. Il11mu-
n o precipi ta tes of C D 44 sp ecies in th e m e lanocyte extrac ts (Fig 2 , 
,.(~ /(t IflIIc) gave a p a t tel11 similar to tota l e xtracts, indicating that 
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F igure 2. Molecular form. of CD44 on melanocytes. Immunoblots 
show several fo rms of CD44 in a crude cxtract and an imll1unoprecipita te 
frO I11 melanocytes . A Tri ton extract was separated by SDS-PA GE and 
il11mulloblotted with the anti-CD4-4 antibody, H-3 (lift laIlC). Alternatively, 
a TrIton extract was immunoprecipi tated with H-3, then separated by 
SDS-PAGE, then iml11unoblottcd with H-3 (righ, lallc). Gels of thcse two 
samples werc run fo r di fferent times, as indica ted by molecular weight 
ITlarkcrs on left and right. 
immul1oprecipitatio l1 could be used to quantitatively puri fy and 
c oncentrate the crude extracts. 
T he pro teoglycan form of C D44 on melanocytes was character-
ized by isolating 35S_I ~be l ed melanocyte proteoglycans, digesting 
t hose. pro teogl ~ca J1S Wltl~ glycosamllloglycan Iyases , and analyzing 
t he dIges ts by sIze exclUSIOn chromatograph y and by W este rn blo ts. 
Nine ty percent of th e total DEAE-purified 35S-labeled proteogly-
c ans from melanocytes w as dIges ted by chondroitin AB C lyase and 
10% by. hepari tinas: (Fig 3). W este rn blo ts of those digests using 
t he anb-CD 44 antIbody, H-3, show ed that the po rtion of the 
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Figure 3. Chromatographic profiles of melanocyte proteoglycans. 
Elution. profil es sh~,: susceptibili ty of melanocyte proteoglycans to diges-
tion wIth chondroItIn ABC lyase and heparitinase. Aliquots of DEAE-
sepha r~se-purifi ~d proteoglycan, containing equal counts of ["S)sul fa tc, 
were dIgested w,d, the indicated enzymes and separated on CL-4 B sepha-
rose. Thc alTO ll'S md,cate the void and included volume of the column. 
T H E JOU RNAL OF INVESTIGATIVE DEllMATOLOGY 
a Q) b Q) 
C/) C/) 
Q) C1l C/) Q) C1l 
C/) Q) C '0 Q) f/l Ql 
-s '0 III CJ) '';:::; 
.l!l E III f/l Q) oE III 'e . § III 'e C C/) >- c: Cii 
.\: .\: 
'0 Q) N .\: '':: '0 
Q) 
III III C OJ C III III c: OJ 
0. 0. 0 '5 w 0. 0. 0 '5 
Ql Q) .L: C Ql Ql .L: C 
I I () :::> ~ I I () :::> 
199- 199-
120- 120 -
87- 87-
Figure 4. Sensitivity of the melanocyte CD44 proteoglycan to 
digestion with various glycosaminoglycan lyase • . a, DEAE-purified 
melanocyte protcoglycall s were digcsted wi th the indicated enzymes and 
separa ted by SDS-PA GE. W cstern blots were probed with H-3 antibody. b. 
imJ1lunoprecipitates of Triton exu'acts frolll mclanocytes were digested with 
the indicated enzymes and separated by SDS-I'AG E. Westcrn blots were 
probed with H-3 antibody. Molecula r weight markers arc indicated. 
pro teoglycan sm ear represen ting CD 44 was redu ced by chondro iti-
nase to a band of 85-95 kDa . By contrast, neither heparinase nor 
heparitinase diminished the proteog lycan smear or induced the 
appearance of a smaller band (Fig 4a), indicating the absence of 
heparan sulfate attachment to the CD44 core protein . Note that the 
85-95-kDa band demonstrated in Fig 2 is absent from Fig 4a. Th.is 
85- 95-kDa band is no t a proteoglycan fo rm of C D 44 and thus 
would not be present in the proteoglycan fractions of the DEAE 
eluate used fo r the experim ent shown in Fig 4a. 
Immunoprecipitates o f all proteoglycan and non-proteoglycan 
species o f C D 44 in melanocyte ex tracts were digested with glycos-
aminoglycan Iyases and then w ere analyzed by SDS-PAGE and 
immun oblotting w ith H- 3. In three experiments 10% of the to tal 
35S_labeled pro teoglycan counts were precipitated by the an ti-
CD44 antibody, indica ting that CD 44 represen ted 10"/., of the to tal 
m elanocyte proteoglycans. C hondro itin ABC lyase greatly reduced 
the pro teoglycan smea r in illlmunoprecipitates and intensifi ed th e 
85-95-kDa band (Fig 4/1). T w o different heparan Iyases, hepari ti-
nase and heparinase , had no effect on the C D44 pro teoglycan band. 
T he experiments shown in Figs 3 and 4 thus demonstrate that the 
proteog lycan fo rm of CD 44 in melanocytes is a chondroitin sulfate 
proteoglycan and that the chondroitin sulfate chain s are attached to 
the C D44H core prote in . A minor band at approx imately 120 kDa 
is seen on the W estern blo ts (Fig 4a,b) and is increased in intensity 
by prediges tion of the extract w ith chondroitinase. 
TPA Changes the Size of the CD44 Proteoglycan Melano-
cytes used in the experiments described above were es tablished and 
maintained in TPA. Since TPA is a tumor promoter and might aH'ect 
the expression of C D44, we de termined whether the same set o f 
CD44 molecul es was produced in melanocytes grown in the 
presence or absence o fTPA . Melanocytes grown in the presence or 
absence ofTPA show ed a taint immunoreacti ve b:llld at 85-95 kDa 
and a high molecular w eight smear on iml11unoblots of immlll1o-
precipitates (Fig Sa) . The modal size of the proteoglycan produced 
by the TPA-treated cells is larger than that fr0 111 the TPA-free cells. 
The size diffe rence in the protcoglycan forms of C D44 is m ore 
clearly evident in autoradiograms of immunoprecipitates (Fig 5b) . 
The 85-95-kDa band is not seen in Fig 5b because it would not be 
labeled with e SS]sultate . C hondroitin lyase digestions of proteo-
glycans resul ted in an immunoreacti ve band of 85-95 kDa from 
both ce ll extracts (data not shown), suggesting tha t a difference in 
the length of the chondroitin sulfate chains accounts for the 
difference in mobili ty of the pro teoglycan smears from TPA-free 
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Figure 5_ Effect ofTPA on melanocyte proteoglycans. SDS-PAGE 
demonstrates dj(fcrcnce in the size of protcogi),cans fr0l11 111clanocytcs cultured 
in the presence or absence ofTPA. c/ , aliquots ofmclaJloc)'te extract containing 
equal runOUllts of protein were illll11l1l1oprecipitated. separated by SDS-PAGE, 
and immLll1oblottcd with 1-1-3. I), inllllunoprecipitated samples of [" S] 
lUlfate-labeled rne lanocyte extracts were subjected to Auorography after 
separation 011 SDS-PAGE. Molecular weight markers are indicated. 
and TPA- treated ce ll s. To estimate the re lative sizes of the glycos-
aminoglycan chains. we generated intact glycosaminoglycan chains 
by alkaline elimina tion of immun oprecipitated CD44 fro m both 
TPA-treated and T PA-free cells. After gel fIltration chromatogra-
phy, TPA- treated cells had Kav = 0.47 and TPA-free cell s had Kav 
= 0.52, indicating tha t individual chondroitin sul fate chain s were 
large r in t he TPA-trcated cc lls. T hese data indicate that glycosami-
noglycan size, ra the r than splice va rian ts of the core protein, 
accounts for differenccs i.n the high molecular weight sm car from 
TPA-free compared to TPA- treated melanocytes . 
mRNA Splice Variants ofCD44 in Melanocytcs Alteruative 
splicing of the CD44 gene transcript gives ri se to various CD44 
mRNA and protein prod ucts in normal and ma lignant ce ll s. PCR of 
melanocyte cDNA was used to detect alternative sp licing in 
melanocytes. Keratinocyte cD N A was used as a positive contro l, 
since extensive alternative splicing occurs in ke ratinocytes (van 
Weering e/ ai, 1993). Primers that spanned the sing le sp lice site 
produced at least six distinct products from kera tinocyte cDNA 
(Fig 6, lalle 6) and a sing le product from m elanocyte cDNA (Fig 6, 
2 
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Figure 6 _ Splice variallts of CD44. Agarosc gel of PCR products using 
eDNA templates fiOln keratinocytes (In li es 2- 6) and from melanocytes 
grown in the presence ofTPA (fnlles 7-11) or in the absence ofTPA (Inlles 
12-16). Primer pa irs used were: internal to cxon 7 (In llcs 2, 7, and 12); in 
exons 5 and 7 (lnllcs 3. 8. and 1 J); in exom 7 and 14 (lnllcs -I, 9, and 14); ill 
exons 8 and 14 (/lI lI es 5. 10, and "15); ill exo llS 5 and IS (Inllcs 6, 1"1 , and 16). 
The latter primer-pair spans the splice site. DNA ladder is shown in lnllc 1. 
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lalles 11 and 16). T he sin gle m elanocyte product is the size expected 
for an mRNA that codes for CD44H . Surprisingly, primers that 
amplify exon 7 alone produced a single product in m elanocytes 
(Fig 6, lnlles 7 and 12) and, as expected, in keratinocytes (Fig 6, 
lalle 2). Prim ers that extend fI'om exon 5 through exon 7 also 
produced a single product in keratinocytes (Fig 6, lalle 3) and in 
melanocytes (Fig 6, Imles 8 and 13). While the results using 
exon- specifIc primers indicate the ex.istence of an exon 7-contain-
ing mR.NA, the absence of a second band when spanning primers 
were used suggests that the amount of CD44H mRNA is m uch 
g reater than any tha t contains exon 7. Pt;mers that arc interna l to 
the sp lice site and span several exons give several products in 
keratinocytes (Fig 6, lalles 4 and 5) but no products in melanocytes 
(Fig 6 , IGlles 9, 10, 14, and 15). Together, these data indicate that 
melanocytes contain mRN A fo r the standard form ofCD44 and for 
a splice variant that con tains ex on 7. It should be noted that 
melanocytes grown in TPA (Fig 6, lalles 7-1 1) gave the same 
results as those grown in the absence ofTPA (Fig 6 , lalles 12-16). 
DISCUSSION 
Severa l forms of CD44 are found on cultured epidermal melano-
cytes. O ne, identifi ed by the 85-95-kOa ba nd on SOS- PAGE and 
coded by the mRN A tha t lacks any alternative ly sp liced exons, 
represents CD44H. the hematopoietic or standard CD44 glycopro-
tein found on many cells. T he core protein for C044H has a 
predicted mass of 37 kDa. Even allowing for 10 kDa of N-linked 
and 15 kDa of O-linked o ligosaccharides, which are known to 
modify this core protein Oa lkanen el ai, 1988), CD44H has an 
anomalously slow mobility on SOS gels. Variations in the oligosac-
charides on this form of C044 have not been identifIed, and the 
mobi li ty of CD44H on SDS-PAGE has been consistently reported 
as 85- 95 kDa afte r extraction from many cell types. 
T he second major form of CD44 on melanocytes was found in 
the smear extending from approximately 160 to > 250 kDa on 
Western bl ots. T his smear disappeared after treatment w ith chon-
droitin ABC lyase, indicating that it represented chondroitin sulfate 
proteoglycan forms ofCD44. T he core protein of that proteoglycan 
was shown to be CD44H , since digests of the proteoglycan fraction 
from melanocytes revealed a n ew 85-95-kDa band on Western 
blots and diges ts of the tota l CD44 population in immunoprecipi-
tates from melanocytes augmented the CD44 band at 85-95 kDa. 
T lus chondro itin su lfate form of CD44 has been previously identi-
fied on lymphocytes Oalkanen el ai, 1.988). melanoma cell s (Faassen 
el ai, 1992), and cells transfected w ith various forms of C044 
(Stamenkovic cl aI, 199 1; Haggerty <'I al . 1992), and m ay be more 
widespread than previously appreciated. For example, van Muijen 
el al (1995) looked for CD44 on normal melanocytes by using 
autoradiography of immunoprecipi tates of e SSjmethionine-labcled 
extracts and identifIed only the 85-95-kOa form of C044H. By 
contrast, our immunoblots of immunoprecipitates and autoradio-
grams of 35S0 "-labeled extracts readily demonstrated the proteo-
g lycan sm ear. T he sm ear. which is characteristic of proteoglycans, 
spreads the chondro itin sul f.,te form of C044 over a large area of 
the gel, and can only be detected using m ethods- such as Western 
blotting or 35S0., labe ling of su lfates on chondroitin sulfate-that 
a.re m ore sensitive than labeling the rare m ethionines in a prote in . 
T he PCR data show that CD44H is the predominant CD44 
mRNA in m elanocytes. Primer pairs that span the sp lice junction 
amplifIed o nly a C044 h cDNA and fa il ed to detect any splice 
variants. Surprisingly. exon 7 was detected using two sets of 
primers, one that would amplit)' ex on 7 alone and one that wou ld 
amplifY a fusion of exons 5 and 7. An exon 7 product was not 
fou nd, however, with the spanning pt;mers. Were exon 7 ex-
pressed as a protein , we might expect to have seen a heparan sul f<lte 
proteoglycan Oackson cl ai, 1995) o r immunorea ctivity with the 
exon 7-specifIc antibody. T he ex on 7 mR.NA m ay not be tratlS-
lated. Failure to trans late C044 mRNAs m ay not be unusual: other 
workers have identified more than a dozen variant mRNAs in 
keratinocytes and have suggested that all are not translated (van 
Weering el ai, 1993). A single minor form of CD44 was identifIed 
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at approximatcly 116 kDa on our Wcstern blots. A lth o ugh it is 
much larger than expected for a variant conta ining exon 7 alon e, 
we havc no de finitive proof that it does not contain the exon 7 
peptide. In our hands, co mm ercially availabl e anti-exon 7 antibod-
ies did not recognize this protein or others known to contain cxon 
7 on Wcstern blots. Dcfinitive statemcnts about the presence or 
absence of CD44 variants containing the ex on 7 peptide await the 
ava ilability of better antibodies. 
A number of interes ting correlations have been made between 
cell behavior and CD44 expression o n m elanom a cells ;11 IJ;tro and 
;11. ";"0. Invasion of melanoma cell s into collagen gels has been 
attributed to ce ll surface expression of a chondroitin sulfate pro-
teoglyC;II1 , and a chondroitin sulfate protcoglyc3n form of CD44 
seemed to be the responsible proteoglycan (Faassen ci ai, 1992). 
T he ability of transforming growth facto r-f3 to augment ;11 IJ;lm 
moti lity and invasiveness of m elanoma cells was attributed to its 
ability to increase expressio n of a chondroitin sul fate proteoglycan 
form of CD44 on those me lanoma cell s (Faassen e( ai, 1993). 
Melanoma ce lJ motili ty ;11 1 ;(ro has also becn correla ted with the 
level of CD44 expression in melanoma cells transfected with CD44 
(Byers cl ai, 1992) and with the level of CD44 synth esized (van 
Muijen e( ai, 1995) or expressed o n spontaneously arising melano-
mas (Birch et ai, 1992; Thomas el ai, 1993). A correlatio n betwcen 
metastatic potential and surface exprcssion of CD44 on cloned 
isolates fi'om a single m elanoma (Birch e( ai, 1992) was reported by 
one group, who more recently concluded that such a correla tio n 
might not be valid when app]jed to the comparison of different 
melanomas (East el ai , 1993) . The role for CD44 ill expel:imenta l 
tumor cell metastasis (Giinthert eI ai, 1991; Sy e( ai, 1991) includes 
one report in which experimental metastasis of a melanoma lin c 
was inhibited by an anti-CD44 antibody (Guo el ai, 1994). 
Onc impli cation of our data is that high levels of CD44 ex prcs-
sion 0/' expressio n of chondroitin sulfate forms of CD44 are not 
themselvcs sufficient to confer an abnormally aggressive Or invasivc 
phenotypc on melanocytes. As one of the m any transmembrane 
links between the extracellular matrix and the cytoske leton, CD44 
may have a pcrmissive but not determining role in certain types of 
cell behavior. 'The question then arises as to whether the two forms 
of CD44 on mclanocytes have different functions . It is tempting to 
specula te that the two forms arc targeted to difFerent parts of the 
cell and that onc form might interact with maU'ix mol ecul es in 
the ba scment membrane and thc oth er with the hyaIuronan in thc 
intercellular spacc. M c lanocytes adhcre to fibron ecti n ;11 Ililro 
(Zambruno e( ai, 1993; Hara e( ai, 1994). While f31-integrins seem 
to be impo rtant in ad hesio n to fibron ecti n (Zambruno ef ai, 1993; 
\-lara e( ai , 1994) , perhaps the chondroitin sulfate form ofCD44 also 
contributes to melanocyte adhesio n to fibronectin. T hc abundant 
expression of CD44 that wc found at the tips of melan ocyte 
dendrites suggests a role for CD44 in dendritic extension through 
the hya luronan-ri ch intcrcellul ar space between kcratinocytes. T his 
suggestion shou ld be cxperim entall y tested, yet experience with 
examining integrins on me lanocytcs has shown that data dcrived 
from mclanocytcs ;11 11;11'0 m ay not bc applicable to melanocytes ;11 
V;IIO: ce rtain intcgrins (au and f31) are found over the enti re surface 
of cultivated melanocytes, while others (a2 , a, and a v f33) are found 
only on dcndrites (Hara eI ai, 1.994). But several of those integrins 
localized to dendri tes ;11 II;tro are undetecta ble on m elanocyte 
dcndritcs ;/1. V;IJO (Zambruno e( ai, 1993) , an obscrvation that 
tempcrs conclusions about their functional signifi cance ;11 IJ ;Jlo. 
Severa l intriguing functional roles for CD44 o n melanocytes are 
plausible. A clear defi ni tion of those roles will requirc a more 
thorough unders tanding of where on thc ceIl surface the two forms 
of CD44 are localized and whether those forms of CD44 function 
primarily as adhcsion molecules, as matri x-to-cytoskeleton signal-
tra nsducing molccules or both. 
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